Literature DB >> 4331801

Serum follicular-stimulating hormone and luteinizing hormone as measured by radioimmunoassay correlated with sexual development in hypopituitary subjects.

R Penny, T P Foley, R M Blizzard.   

Abstract

Serum follicular-stimulating hormone (FSH) and luteinizing hormone (LH) as determined by radioimmunoassay, were correlated with sexual development in 29 patients with hypopituitarism (ages 14.2-29.9 yr).16 of 25 idiopathic hypopituitary patients (20 males and 5 females) exhibited some degree of sexual development. Stage III of sexual development or beyond was achieved by 12 of the 16. Of 13 patients with growth hormone (GH), adrenocortical-stimulating hormone (ACTH), and thyroid-stimulating hormone (TSH) deficiency, 8 did not develop beyond stage I. In contrast, five of six patients with GH deficiency without ACTH or TSH deficiency developed to stage III of sexual development or beyond. The mean (+/-sd) serum LH concentration while in stage I (4.3 +/-0.9 mIU/ml) of eight patients (seven males and one female) who developed beyond stage I was significantly (P < 0.005) greater than the mean serum LH concentration (2.3 +/-0.9 mIU/ml) in nine patients (seven males and two females) who had not developed beyond stage I. Mean serum FSH concentrations were not different. Three of four males with organic hypopituitarism did not develop beyond stage I of sexual development. Serum FSH and LH concentrations in the idiopathic and organic hypopituitary patients were more compatible with stage of sexual development than with age. A serum LH concentration below the range of normal for stage I of sexual development in a prepubertal patient suggests that the patient will remain sexually infantile as an adult.

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4331801      PMCID: PMC332931          DOI: 10.1172/JCI106799

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  16 in total

1.  Hereditary pituitary dwarfism with spontaneous puberty.

Authors:  M Seip; C B Van Der Hagen; O Trygstad
Journal:  Arch Dis Child       Date:  1968-02       Impact factor: 3.791

2.  Radioimmunoassay of human follicle stimulating and luteinizing hormones in plasma.

Authors:  B B Saxena; H Demura; H M Gandy; R E Peterson
Journal:  J Clin Endocrinol Metab       Date:  1968-04       Impact factor: 5.958

3.  Radioimmunoassay for human follicle stimulating hormone.

Authors:  C Faiman; R J Ryan
Journal:  J Clin Endocrinol Metab       Date:  1967-03       Impact factor: 5.958

4.  Radioimmunoassay: a method for human chorionic gonadotropin and human luteinizing hormone.

Authors:  A R Midgley
Journal:  Endocrinology       Date:  1966-07       Impact factor: 4.736

5.  Radioimmunoassay for human luteinizing hormone.

Authors:  W D Odell; G T Ross; P L Rayford
Journal:  Metabolism       Date:  1966-04       Impact factor: 8.694

6.  Radioimmunoassay for human luteinizing hormone.

Authors:  C Faiman; R J Ryan
Journal:  Proc Soc Exp Biol Med       Date:  1967 Aug-Sep

7.  Radioimmunoassay for human follicle-stimulating hormone.

Authors:  A R Midgley
Journal:  J Clin Endocrinol Metab       Date:  1967-02       Impact factor: 5.958

8.  Sexual ateliotic dwarfism: a recessively inherited isolated deficiency of growth hormone.

Authors:  D L Rimoin; T J Merimee; V A McKusick
Journal:  Trans Assoc Am Physicians       Date:  1966

9.  Radioimmunoassay for luteinizing hormone in human plasma or serum: physiological studies.

Authors:  W D Odell; G T Ross; P L Rayford
Journal:  J Clin Invest       Date:  1967-02       Impact factor: 14.808

10.  Measurement of human luteinizing hormone in plasma by radioimmunoassay.

Authors:  D S Schalch; A F Parlow; R C Boon; S Reichlin
Journal:  J Clin Invest       Date:  1968-03       Impact factor: 14.808

View more
  1 in total

Review 1.  Stunted growth with more or less normal appearance.

Authors:  J R Bierich; H Enders; U Heinrich; R Huenges; M B Ranke; D Schoenberg
Journal:  Eur J Pediatr       Date:  1982-12       Impact factor: 3.183

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.